Page results
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
A world-first treatment for Creutzfeldt-Jakob disease (CJD) has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.
-
Penile plication (Nesbit) procedure post-operative information
-
Information on the insertion of an inflatable penile prosthesis
-
Patient Advice and Liaison Service (PALS)
-
UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Information about the Integrated Women's Service at the RLHIM patient information leaflet
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
File results
-
FOI/2022/0679 - Theatre management, AA's and ODPs
-
FOI/2022/0681 - Deep brain stimulation procedure
-
FOI/2022/0686 - Breast cancer patients
-
FOI/2022/0692 - Respiratory diagnostic equipment
-
FOI/2022/0696 - Trust complaints policy and discrimination and diversity policy
-
FOI/2022/0704 - Elective operations cancelled for non-clinical reasons
-
FOI/2022/0705 - Head/ neck and urothelial cancer treatment
-
FOI/2022/0742 - Allegations of sexual misconduct in NHS Trusts
-
FOI/2022/0741 - Number of women in the maternity service identified as needing an interpreter
-
FOI2017208 Patient meals